Wadsak, W., & Mitterhauser, M. (2010). Basics and principles of radiopharmaceuticals for PET/CT. European Journal of Radiology, 73(3), 461-469. https://doi.org/10.1016/j.ejrad.2009.12.022

Häusler, D., Nics, L., Mien, L-K., Ungersböck, J., Lanzenberger, R., Shanab, K., Sindelar, K. M., Viernstein, H., Wagner, K-H., Dudczak, R., Kletter, K., Wadsak, W., & Mitterhauser, M. (2010). [18F]FE@SUPPY and [18F]FE@SUPPY:2 - metabolic considerations. Nuclear Medicine and Biology, 37(4), 421-426. https://doi.org/10.1016/j.nucmedbio.2010.01.001

Wadsak, W., Mien, L-K., Shanab, K., Weber, K., Schmidt, B., Sindelar, K. M., Ettlinger, D. E., Häusler, D., Spreitzer, H., Keppler, B., Viernstein, H., Dudczak, R., Kletter, K., & Mitterhauser, M. (2009). Radiosynthesis of the adenosine a3 receptor ligand 5-(2-[18F]fluoroethyl)2,4,-diethyl-3-(ethylsulfanylcarbonyl)-6-phenylpyridine-5-carboxylate([18F]FE@SUPPY). Radiochimica Acta: international journal for chemical aspects of nuclear science and technology, 96(2), 119-124. https://doi.org/10.1524/ract.2008.1467

Mitterhauser, M., Häusler, D., Mien, L-K., Ungersböck, J., Nics, L., Lanzenberger, R., Sindelar, K. M., Viernstein, H., Dudczak, R., Kletter, K., Spreitzer, H., & Wadsak, W. (2009). Atomatisation and First Evaluation of [18F]FE@SUPPY:2, an Alternative PET-Tracer for the Adenosine A3 Receptor: A Comparison with [18F]FE@SUPPY. The Open Nuclear Medicine Journal, 1, 15-23. https://doi.org/10.2174/1876388X00901010015

Spindelegger, C., Lanzenberger, R., Wadsak, W., Mien, L-K., Stein, P., Mitterhauser, M., Moser, U., Holik, A., Pezawas, L. M., Kletter, K., & Kasper, S. (2009). Influence of escitalopram treatment on 5-HT 1A receptor binding in limbic regions in patients with anxiety disorders. Molecular Psychiatry, 14(11), 1040-1050. https://doi.org/10.1038/mp.2008.35

Fink, M., Wadsak, W., Savli, M., Stein, P., Moser, U., Hahn, A., Mien, L-K., Kletter, K., Mitterhauser, M., Kasper, S., & Lanzenberger, R. (2009). Lateralization of the serotonin-1A receptor distribution in language areas revealed by PET. NeuroImage, 45(2), 598-605. https://doi.org/10.1016/j.neuroimage.2008.11.033

Haeusler, D., Mitterhauser, M., Mien, L-K., Shanab, K., Lanzenberger, R. R., Schirmer, E., Ungersboeck, J., Nics, L., Spreitzer, H., Viernstein, H., Dudczak, R., Kletter, K., & Wadsak, W. (2009). Radiosynthesis of a novel potential adenosine A(3) receptor ligand, 5-ethyl 2,4-diethyl-3-((2-[F-18]fluoroethyl)sulfanylcarbonyl)-6-phenylpyridine-5-carboxylate ([F-18]FE@SUPPY:2). Radiochimica Acta: international journal for chemical aspects of nuclear science and technology, 97(12), 753-758. https://doi.org/10.1524/ract.2009.1663

Haeusler, D., Mien, L-K., Nics, L., Ungersböck, J., Philippe, C., Lanzenberger, R., Kletter, K., Dudczak, R., Mitterhauser, M., & Wadsak, W. (2009). Simple and rapid preparation of [11C]DASB with high quality and reliability for routine applications. Applied Radiation and Isotopes, 67(9), 1654-1660. https://doi.org/10.1016/j.apradiso.2009.03.005

Shanab, K., Wadsak, W., Mien, L. K., Mitterhauser, M., Holzer, W., Polster, V. P., Viernstein, H., & Spreitzer, H. (2008). Synthesis of in vivo metabolites of the new adenosine A(3) receptor PET-radiotracer [(18)F]FE@SUPPY. Heterocycles, 75(2), 339-356. https://doi.org/10.3987/COM-07-11219

Wadsak, W., Mien, L-K., Shanab, K., Ettlinger, D. E., Haeusler, D., Sindelar, K., Lanzenberger, R. R., Spreitzer, H., Viernstein, H., Keppler, B. K., Dudczak, R., Kletter, K., & Mitterhauser, M. (2008). Preparation and first evaluation of [F-18]FE@SUPPY: a new PET tracer for the adenosine A(3) receptor. Nuclear Medicine and Biology, 35(1), 61-66. https://doi.org/10.1016/j.nucmedbio.2007.09.004

Mien, L-K., Wadsak, W., Shanab, K., Ettlinger, D., Spreitzer, H., Viernstein, H., Dudczak, R., Kletter, K., Mitterhauser, M., & Keppler, B. (2008). Radiosynthesis of the adenosin A3 receptor ligand 5-(2[18F]fluoroethyl)-diethyl-3-(ethylsulfanylcarbonyl)-6-phenylpyridine-5-carboxylate ([18F]FE@SUPPY). Radiochemistry, (96), 119-124.

Mitterhauser, M., & Tögel, S. (2008). What to consider in the development of new bone seekers: Mechanistic and tracer-related aspects. Nuclear Medicine and Biology, 35(8), 817-824.

Mitterhauser, M., Wadsak, W., Mien, L-K., Eidherr, H., Roka, S., Zettinig, G., Angelberger, P., Viernstein, H., Kletter, K., & Dudczak, R. (2007). The labelling of Nanocoll(R) with [111In] for dual-isotope scanning. Applied Radiation and Isotopes, 59(5-6), 337-342. http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6TJ0-49V77YN-2&_user=464575&_coverDate=12%2F31%2F2003&_rdoc=9&_fmt=summary&_orig=browse&_srch=doc-info(%23toc%235296%232003%23999409994%23470264%23FLA%23display%23Volume)&_cdi=5296&_sort=d&_docanchor=&_ct=20&_acct=C000022258&_version=1&_urlVersion=0&_userid=464575&md5=f734ad25773850690d15254e0e9c757f

Wadsak, W., Mien, L-K., Ettlinger, D. E., Eidherr, H., Haeusler, D., Sindelar, K. M., Keppler, B., Dudczak, R., Kletter, K., & Mitterhauser, M. (2007). 18F fluoroethylations: different strategies for the rapid translation of 11C-methylated radiotracers. Nuclear Medicine and Biology, 34(8), 1019-1028. https://doi.org/10.1016/j.nucmedbio.2007.06.012

Tögel, S., Mien, L-K., Wadsak, W., Eidherr, H., Viernstein, H., Kluger, R., Ettlinger, D., Kletter, K., Dudczak, R., & Mitterhauser, M. (2006). In vitro evaluation of no carrier added, carrier added and cross-complexed [90Y]-EDTMP provides evidence for a novel "foreign carrier theory". Nuclear Medicine and Biology, 33(1), 95-99. http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T9Y-4J62P22-G&_user=464575&_coverDate=01%2F31%2F2006&_rdoc=14&_fmt=summary&_orig=browse&_srch=doc-info(%23toc%235127%232006%23999669998%23616107%23FLA%23display%23Volume)&_cdi=5127&_sort=d&_docanchor=&_ct=23&_acct=C000022258&_version=1&_urlVersion=0&_userid=464575&md5=30cb7ace21360428965c20207094606b

Czejka, M., Mitterhauser, M., Farkouh, A., & Ostermann, E. (2006). In-vivo disposition of irinotecan (CPT-11) and its metabolites in combination with the monoclonal antibody cetuximab. Anticancer Research: International journal of cancer research and treatment, (26), 1337-1341. http://ar.iiarjournals.org/content/26/2B/1337.full.pdf

Wadsak, W., Wirl-Sagadin, B., Mitterhauser, M., Mien, L-K., Ettlinger, D. E., Keppler, B., Dudczak, R., & Kletter, K. (2006). NCA nucleophilic radiofluorination on substituted benzaldehydes for the preparation of [18F]fluorinated aromatic amino acids. Applied Radiation and Isotopes, 64(3), 355-359. http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6TJ0-4HMNFXB-3&_user=464575&_coverDate=03%2F31%2F2006&_rdoc=11&_fmt=summary&_orig=browse&_srch=doc-info(%23toc%235296%232006%23999359996%23613704%23FLA%23display%23Volume)&_cdi=5296&_sort=d&_docanchor=&_ct=19&_acct=C000022258&_version=1&_urlVersion=0&_userid=464575&md5=74cdc33af1dd242be8658fdbd6546b87

Tögel, S., Hoffmann, O., Wadsak, W., Ettlinger, D. E., Mien, L-K., Wiesner, K., Nguemo, J., Viernstein, H., Kletter, K., Dudczak, R., & Mitterhauser, M. (2006). Uptake of bone-seekers is solely associated with mineralisation! A study with 99mTc-MDP, 153Sm-EDTMP and 18F-fluoride on osteoblasts. European Journal of Nuclear Medicine and Molecular Imaging, 33(4), 491-494. https://doi.org/10.1007/s00259-005-0026-x

Ettlinger, D. E., Wadsak, W., Mien, L-K., Machek, M., Wabnegger, L., Rendl, G., Karanikas, G., Viernstein, H., Kletter, K., Dudczak, R., & Mitterhauser, M. (2006). [18F]FETO: Metabolic considerations. European Journal of Nuclear Medicine and Molecular Imaging, 33(8), 928-931. http://www.springerlink.com/content/ym3134638318w24l/?p=ad245f8ab07440ea97d2c45bcce1dee8&pi=11

Mitterhauser, M., Wadsak, W., Eidherr, H., Viernstein, H., Dudczak, R., & Kletter, K. (2005). New aspects on the preparation of [11C]Methionine - A simple and fast online approach without preparative HPLC. Applied Radiation and Isotopes, 62(3), 441-445. http://www.scopus.com/scopus/inward/record.url?eid=2-s2.0-10644254550&partner@&rel=R5.0.4